Literature DB >> 14695842

Highly diverse heparan sulfate analogue libraries: providing access to expanded areas of sequence space for bioactivity screening.

Edwin A Yates1, Scott E Guimond, Jeremy E Turnbull.   

Abstract

Structurally diverse heparan sulfate analogue libraries were produced chemicoenzymatically from heparin. They possess vastly more heterogeneity than tissue heparan sulfates, expand the sequence space available for screening, and can help identify minimal structural features associated with activity. Library components are likely to exhibit fewer nonspecific interactions and side-effects than heparin or simple chemically modified heparin. A strategy for their use is illustrated for the fibroblast growth factor-receptor tyrosine kinase signaling system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695842     DOI: 10.1021/jm0309755

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

Authors:  Sailaja Arungundram; Kanar Al-Mafraji; Jinkeng Asong; Franklin E Leach; I Jonathan Amster; Andre Venot; Jeremy E Turnbull; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

Review 2.  Heparan sulfate and heparin interactions with proteins.

Authors:  Maria C Z Meneghetti; Ashley J Hughes; Timothy R Rudd; Helena B Nader; Andrew K Powell; Edwin A Yates; Marcelo A Lima
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

3.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation.

Authors:  Vaishali N Patel; Karen M Likar; Simona Zisman-Rozen; Samuel N Cowherd; Keyonica S Lassiter; Ifat Sher; Edwin A Yates; Jeremy E Turnbull; Dina Ron; Matthew P Hoffman
Journal:  J Biol Chem       Date:  2008-01-28       Impact factor: 5.157

5.  Heparin interacts with elongation factor 1α of Cryptosporidium parvum and inhibits invasion.

Authors:  Atsuko Inomata; Fumi Murakoshi; Akiko Ishiwa; Ryo Takano; Hitoshi Takemae; Tatsuki Sugi; Frances Cagayat Recuenco; Taisuke Horimoto; Kentaro Kato
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

6.  Glycomics approaches for the bioassay and structural analysis of heparin/heparan sulphates.

Authors:  Tania M Puvirajesinghe; Jeremy E Turnbull
Journal:  Metabolites       Date:  2012-11-28

Review 7.  Heparan sulphate, its derivatives and analogues share structural characteristics that can be exploited, particularly in inhibiting microbial attachment.

Authors:  T R Rudd; A Hughes; J Holman; V Solari; E de Oliveira Ferreira; R M Cavalcante Pilotto Domingues; E A Yates
Journal:  Braz J Med Biol Res       Date:  2012-04-05       Impact factor: 2.590

Review 8.  Glycoarray Technologies: Deciphering Interactions from Proteins to Live Cell Responses.

Authors:  Tania M Puvirajesinghe; Jeremy E Turnbull
Journal:  Microarrays (Basel)       Date:  2016-01-04

9.  Molecular Origins of the Compatibility between Glycosaminoglycans and Aβ40 Amyloid Fibrils.

Authors:  Katie L Stewart; Eleri Hughes; Edwin A Yates; David A Middleton; Sheena E Radford
Journal:  J Mol Biol       Date:  2017-07-10       Impact factor: 6.151

10.  Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation.

Authors:  Jennifer R Higginson; Sophie M Thompson; Alessandra Santos-Silva; Scott E Guimond; Jeremy E Turnbull; Susan C Barnett
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.